Search research articles
Contact Us
Filters
Showing results (561-570 of 1,135) with videos related to
Page
of 114
Sort By:
The EMBO Journal
|
September 1, 1992
Multiple sites for double-strand breaks in whole meiotic chromosomes of Saccharomyces cerevisiae
D Zenvirth, T Arbel, A Sherman, et al.
Behavior Modification
|
January 9, 2004
Behavioral interventions to reduce the pica of persons with developmental disabilities
David B McAdam, James A Sherman, Jan B Sheldon, et al.
Biophysical Journal
|
December 7, 2000
The phantom burster model for pancreatic beta-cells
R Bertram, J Previte, A Sherman, et al.
Nature Communications
|
August 31, 2019
Identification of somatic mutations in single cell DNA-seq using a spatial model of allelic imbalance
Lovelace J Luquette, Craig L Bohrson, Max A Sherman, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
July 1, 1990
Temporal stability of paraspinal electromyographic recordings in low back pain and non-pain subjects
J G Arena, R A Sherman, G M Bruno, et al.
Nature Communications
|
January 27, 2011
High rates of photobiological H2 production by a cyanobacterium under aerobic conditions
Anindita Bandyopadhyay, Jana Stöckel, Hongtao Min, et al.
Journal of Applied Behavior Analysis
|
January 1, 1990
Balancing the right to habilitation with the right to personal liberties: the rights of people with developmental disabilities to eat too many doughnuts and take a nap
D J Bannerman, J B Sheldon, J A Sherman, et al.
Medical Care
|
February 1, 1979
Threats to the validity of emergency medical services evaluation: a case study of mobile intensive care units
M A Sherman, G J Rath, J L Schofer, et al.
The American Journal of Physiology
|
January 1, 1994
Hydrogen peroxide cytotoxicity in cultured cardiac myocytes is iron dependent
R M Byler, N A Sherman, J S Wallner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 11, 2004
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer
Carol A Sherman, James E Herndon, Dorothy M Watson, et al.
Page
of 114
Search research articles
Search
Showing results (561-570 of 1,135) with videos related to
Sort By:
Page
of 114
The EMBO Journal
|
September 1, 1992
Multiple sites for double-strand breaks in whole meiotic chromosomes of Saccharomyces cerevisiae
D Zenvirth, T Arbel, A Sherman, et al.
Behavior Modification
|
January 9, 2004
Behavioral interventions to reduce the pica of persons with developmental disabilities
David B McAdam, James A Sherman, Jan B Sheldon, et al.
Biophysical Journal
|
December 7, 2000
The phantom burster model for pancreatic beta-cells
R Bertram, J Previte, A Sherman, et al.
Nature Communications
|
August 31, 2019
Identification of somatic mutations in single cell DNA-seq using a spatial model of allelic imbalance
Lovelace J Luquette, Craig L Bohrson, Max A Sherman, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
July 1, 1990
Temporal stability of paraspinal electromyographic recordings in low back pain and non-pain subjects
J G Arena, R A Sherman, G M Bruno, et al.
Nature Communications
|
January 27, 2011
High rates of photobiological H2 production by a cyanobacterium under aerobic conditions
Anindita Bandyopadhyay, Jana Stöckel, Hongtao Min, et al.
Journal of Applied Behavior Analysis
|
January 1, 1990
Balancing the right to habilitation with the right to personal liberties: the rights of people with developmental disabilities to eat too many doughnuts and take a nap
D J Bannerman, J B Sheldon, J A Sherman, et al.
Medical Care
|
February 1, 1979
Threats to the validity of emergency medical services evaluation: a case study of mobile intensive care units
M A Sherman, G J Rath, J L Schofer, et al.
The American Journal of Physiology
|
January 1, 1994
Hydrogen peroxide cytotoxicity in cultured cardiac myocytes is iron dependent
R M Byler, N A Sherman, J S Wallner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 11, 2004
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer
Carol A Sherman, James E Herndon, Dorothy M Watson, et al.
Page
of 114